Article Details

Abivax Receives Approval for ABX464 Phase 1 Study in Japanese Subjects for Subsequent ...

Retrieved on: 2021-08-17 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

Abivax Receives Approval for ABX464 Phase 1 Study in Japanese Subjects for Subsequent .... View article details on hiswai:

Excerpt

... biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral infections, and ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up